摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2-chloro-benz[a]anthracene-7,12-dione | 49600-94-4

中文名称
——
中文别名
——
英文名称
2-chloro-benz[a]anthracene-7,12-dione
英文别名
2-Chlor-benz[a]anthracen-7,12-dion;2-Chlorobenzo[a]anthracene-7,12-dione
2-chloro-benz[<i>a</i>]anthracene-7,12-dione化学式
CAS
49600-94-4
化学式
C18H9ClO2
mdl
——
分子量
292.721
InChiKey
PBRGPBYPTAJJFK-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    222-223 °C
  • 沸点:
    500.0±19.0 °C(Predicted)
  • 密度:
    1.426±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    4.7
  • 重原子数:
    21
  • 可旋转键数:
    0
  • 环数:
    4.0
  • sp3杂化的碳原子比例:
    0.0
  • 拓扑面积:
    34.1
  • 氢给体数:
    0
  • 氢受体数:
    2

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    2-chloro-benz[a]anthracene-7,12-dione 作用下, 生成 2-amino-benz[a]anthracene-7,12-dione
    参考文献:
    名称:
    Tsunoda, Yuki Gosei Kagaku Kyokaishi, 1951, vol. 9, # 5, p. 23,24, 26
    摘要:
    DOI:
  • 作为产物:
    描述:
    1,4-萘醌 以33%的产率得到
    参考文献:
    名称:
    MANNING W. B.; TOMASZEWSKI J. E.; MUSCHIK G. M.; SATO R. I., J. ORG. CHEM., 1977, 42, NO 22, 3465-3468
    摘要:
    DOI:
点击查看最新优质反应信息

文献信息

  • Strongly Deformed TCNQ Derivatives: Syntheses and Properties of 7,12-Bis(dicyanomethylene)-7,12-dihydrobenz[<i>a</i>]anthracene (BDCNBA) Derivatives
    作者:Kazuhiro Maruyama、Hiroshi Imahori、Katsuhiko Nakagawa、Nobuo Tanaka
    DOI:10.1246/bcsj.62.1626
    日期:1989.5
    In spite of large steric repulsion between aromatic quinone moiety and dicyanomethylene moiety the title compounds (BDCNBA) were synthesized by TiCl4-catalyzed reactions of the corresponding aromatic quinones and malononitrile. BDCNBA showed electronic spectra indicating the intramolecular charge-transfer interaction and redox properties similar to 11,11,12,12-tetracyano-9,10-anthraquinodimethane (TCNAQ)
    尽管芳族醌部分和二氰基亚甲基部分之间存在大的空间排斥,但标题化合物 (BDCNBA) 是通过相应的芳族醌和丙二腈的 TiCl4 催化反应合成的。BDCNBA 显示的电子光谱表明分子内电荷转移相互作用和氧化还原特性类似于 11,11,12,12-tetracyano-9,10-anthraquinodimethane (TCNAQ) 衍生物。BDCNBA 显示出低电导率 (≈10−7 Ω−1 cm−1)。通过 X 射线晶体学分析建立了 BDCNBA 的强烈变形结构。
  • Developing solution and method of forming polyimide pattern by using the developing solution
    申请人:Yoshiaki Kawamonzen
    公开号:US20010006767A1
    公开(公告)日:2001-07-05
    Disclosed is a developing solution for a photosensitive polyimide, which consists of an aqueous solution of an amine compound having a base dissociation index pKb [=−log (Kb)=−log (Kw/Ka)=14−pKa, where Kb is a base dissociation constant, Ka is acid dissociation constant of a proton complex, pKa is an acid dissociation index of a proton complex=−log (Ka), and Kw is an ion product of water=1×10 −14 ] of 5 to 8 within an aqueous solution of 25° C.
    本发明公开了一种用于感光聚酰亚胺的显影液,它由一种胺化合物的水溶液组成,该胺化合物的碱解离指数为 pKb [=-log (Kb)=-log (Kw/Ka)&equals;14-pKa,其中 Kb 是碱解离常数,Ka 是质子络合物的酸解离常数,pKa 是质子络合物的酸解离指数=-log (Ka),Kw 是水的离子积=1×10 -14 ]在 25° C 的水溶液中为 5 至 8。
  • Resin-encapsulated semiconductor apparatus and process for its fabrication
    申请人:Hitachi, Ltd.
    公开号:US20020027268A1
    公开(公告)日:2002-03-07
    The present invention provides a resin-encapsulated semiconductor apparatus comprising a semiconductor device having a ferroelectric film and a surface-protective film, and an encapsulant member comprising a resin; the surface-protective film being formed of a polyimide. The present invention also provides a process for fabricating a resin-encapsulated semiconductor apparatus, comprising the steps of forming a film of a polyimide precursor composition on the surface of a semiconductor device having a ferroelectric film; heat-curing the polyimide precursor composition film to form a surface-protective film formed of a polyimide; and encapsulating, with an encapsulant resin, the semiconductor device on which the surface-protective film has been formed. The polyimide may preferably have a glass transition temperature of from 240° C. to 400° C. and a Young's modulus of from 2,600 MPa to 6 GPa. The curing may preferably be carried out at a temperature of from 230° C. to 300° C.
    本发明提供了一种树脂封装半导体装置,该装置包括具有铁电薄膜和表面保护膜的半导体器件,以及由树脂组成的封装件;表面保护膜由聚酰亚胺形成。本发明还提供了一种制造树脂封装半导体设备的工艺,包括以下步骤:在具有铁电薄膜的半导体设备表面形成聚酰亚胺前体组合物薄膜;热固化聚酰亚胺前体组合物薄膜,形成由聚酰亚胺构成的表面保护膜;以及用封装树脂封装已形成表面保护膜的半导体设备。聚酰亚胺最好具有 240°C 至 400°C 的玻璃转化温度和 2,600 MPa 至 6 GPa 的杨氏模量。固化最好在 230 摄氏度至 300 摄氏度的温度下进行。
  • 355. Polycyclic aromatic amines. Part I
    作者:G. M. Badger
    DOI:10.1039/jr9480001756
    日期:——
  • The Conversion of Phthaloylnaphthalenes and Naphthoyl-2-benzoic Acids into Benzanthraquinones
    作者:Louis F.、Mary Fieser
    DOI:10.1021/ja01335a050
    日期:1933.8
查看更多

同类化合物

酒色霉素 A1 萘并[1,2-b]菲-7,14-二酮 苯并蒽-7,12-二酮 腊伯罗霉素 浅内红霉素 水绫霉素 棣棠霉素 C 抑胃酶氨酰-21 富士霉素A 四角霉素 丙酸,2-甲基-,(3R,4S)-1,2,3,4,7,12-六氢-8-甲氧基-3-甲基-1,7,12-三羰基苯并[a]蒽-4-基酯 丁二酸,碘-,4-乙基1-甲基酯(9CI) N-{4-[(4-吡啶-2-基哌嗪-1-基)羰基]苯基}-7-(三氟甲基)喹啉-4-胺 8-羟基-3-甲基-3,4-二氢-1,7,12(2H)-苯并[a]蒽三酮 8-甲氧基-3-甲基-3,4-二氢-1,7,12(2H)-四苯e三酮 8,11-二[2-(2-羟基乙基氨基)乙基氨基]-6-甲氧基-1,2,3,4-四氢苯并[a]蒽-7,12-二酮 4a,8,12b-三羟基-4-甲基-1H-苯并[a]蒽-2,7,12-三酮 3-甲氧基苯并(a)蒽-7,12-二酮 1,3-二羟基-8-甲氧基-3-甲基-2,4-二氢-1H-苯并[a]蒽-7,12-二酮 (R)-8-羟基-3-甲基-1,2,3,4-四氢苯并[a]蒽-7,12-二酮 (3S)-6-羟基-8-甲氧基-3-甲基-3,4-二氢-2H-苯并[a]蒽-1,7,12-三酮 (3S)-3-甲基-8-[(2S,3R,4R,5R,6S)-3,4,5-三羟基-6-甲基四氢吡喃-2-基]氧基-3,4-二氢-2H-苯并[a]蒽-1,7,12-三酮 (3S)-11-羟基-8-甲氧基-3-甲基-3,4-二氢-2H-苯并[a]蒽-1,7,12-三酮 (3R)-9-[(2R,4R,5R,6R)-4-[(2S,5S,6S)-5-[(2S,4R,5S,6R)-4,5-二羟基-6-甲基四氢吡喃-2-基]氧基-6-甲基四氢吡喃-2-基]氧基-5-羟基-6-甲基四氢吡喃-2-基]-3,8-二羟基-3-甲基-2,4-二氢苯并[b]菲-1,7,12-三酮 (2S,4S,5S)-4-[(1E,3E,5E)-7-[(2R,6R)-6-[(2R,3S,4aR,12bS)-2,3,4A,8,12B-五羟基-3-甲基-1,7,12-三氧代-2,4-二氢苯并[h]菲-9-基]-2-甲基四氢吡喃-3-基]氧基-7-氧代庚-1,3,5-三烯基]-2,5-二甲基-1,3-二氧戊环-2-羧酸 (2R,3S,4aR,12bS)-2,3,4a,8,12b-五羟基-3-甲基-3,4,4a,12b-四氢-1,7,12(2H)-四苯e三酮 (1S,3S)-10-[[(1S,3S)-1,11-二羟基-8-甲氧基-3-甲基-7,12-二氧代-1,2,3,4-四氢苯并[h]菲-10-基]甲基]-1,11-二羟基-8-甲氧基-3-甲基-1,2,3,4-四氢苯并[B]菲-7,12-二酮 (1S,3S)-1-羟基-8-甲氧基-3-甲基-1,2,3,4-四氢苯并[a]蒽-7,12-二酮 (-)-8-O-甲基四角霉素 methyl 9-fluoro-6-hydroxy-8-methoxy-1,2,3,4-tetrahydrobenz[a]anthracene-7,12-dione-2-carboxylate urdamycinone B amycomycin B 6-hydroxy-5-hydroxymethylbenz[a]anthracene-7,12-dione 6-hydroxy-5-methylbenz[a]anthracene-7,12-dione 6-hydroxy-1,5,8-trimethoxy-3-methyltetraphene-7,12-dione 3,6-Dihydroxy-3-methyl-1,2,3,4-tetrahydrobenzanthracene-7,12-dione Moromycin B Moromycin A 1,2,3,11,12,13-Hexamethoxydibenzanthracen-7,14-chinon 4-methoxybenzanthracene-7,12-dione Fujianmycin B (3R,4aR,12bS)-4a,8,12b-trihydroxy-9-[5-(5-hydroxy-6-methyloxan-2-yl)oxy-6-methyloxan-2-yl]-3-methyl-3-[(6-methyl-5-oxo-2H-pyran-2-yl)oxy]-2,4-dihydrobenzo[a]anthracene-1,7,12-trione 4,11-dihydroxy-dibenz[a,h]anthracene-7,14-dione 5-fluoro-1,2,3,4-tetrahydrobenzanthracene-7,12-dione 10-fluoro-1,2,3,4-tetrahydrobenzanthracene-7,12-dione 3-methoxydibenzanthracene-7,14-dione 4-Hydroxy-benzanthracen-7,12-dion 8-Methoxy-1,2,3,4-tetrahydro-benzo[a]anthracene-7,12-dione 1-Hydroxybenzantracen-7,12-chinon 8-methoxy-3-methyl-7,12-dioxy-1,2,3,4-tetrahydro-benzoanthracene-2-dimethylene dithioacetal